CD8 Cis-Targeted IL-2 Drives Potent Antiviral Activity Against Hepatitis B Virus

0
110
Scientists developed a cis-targeted CD8-interleukin-2 fusion protein, aiming to selectively stimulate dysfunctional CD8+ T cells in chronic hepatitis B virus.
[Science Translational Medicine]
Abstract